Armistice Capital »

M/a shares owned by Armistice Capital

Quarter-by-quarter ownership of M/a (MTSI) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in M/a

Tip: Access up to 7 years of quarterly data

All positions including M/a held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in M/a by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.7M 17k 222.07

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding M/a

FMR
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Invesco
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Wellington Management Company
Geode Capital Management
Capital Research Global Investors
Whale Rock Capital Management
Artisan Partners Limited Partnership
Jennifer Ranahan
Massachusetts Financial Services

View all funds holding M/a